Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis.
Tang T, Wang G, Liu S, Zhang Z, Liu C, Li F, Liu X, Meng L, Yang H, Li C, et al. Sci Rep. 2021 Jan 12; 11(1):631. Epub 2021 Jan 12.